Terms: = Lung cancer AND TRIM33, RFG7, 51592, ENSG00000197323, Q9UPN9, TF1G, FLJ32925, TIF1G, PTC7, TIFGAMMA, TIF1GAMMA
33 results:
1. Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis.
Fornaro M; Girolamo F; Giannini M; Coladonato L; Capuano A; Capodiferro M; D'Abbicco D; Ruggieri M; Mastrapasqua M; Iannone F
Clin Exp Rheumatol; 2024 Feb; 42(2):288-294. PubMed ID: 38488091
[TBL] [Abstract] [Full Text] [Related]
2. Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review.
Kilinc OC; Ugurlu S
Autoimmun Rev; 2023 Dec; 22(12):103464. PubMed ID: 37863375
[TBL] [Abstract] [Full Text] [Related]
3. [Risk factors analysis and prediction model establishment of malignant tumor in patients with polymyositis/dermatomyositis].
Wang YF; Li HX; Feng Y; Zhang Y; Wu ZB
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(25):1903-1910. PubMed ID: 37402671
[No Abstract] [Full Text] [Related]
4. Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification.
Elkrief A; Odintsov I; Markov V; Caeser R; Sobczuk P; Tischfield SE; Bhanot U; Vanderbilt CM; Cheng EH; Drilon A; Riely GJ; Lockwood WW; de Stanchina E; Tirunagaru VG; Doebele RC; Quintanal-Villalonga Á; Rudin CM; Somwar R; Ladanyi M
J Thorac Oncol; 2023 Sep; 18(9):1165-1183. PubMed ID: 37182602
[TBL] [Abstract] [Full Text] [Related]
5. Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma.
Schrenk KG; Weschenfelder W; Spiegel C; Agaimy A; Stöhr R; Hartmann A; Gaßler N; Drescher R; Freesmeyer M; Malouhi A; Bürckenmeyer F; Aschenbach R; Teichgräber U; Kögler C; Vogt M; Hofmann GO; Hochhaus A
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5493-5496. PubMed ID: 36469155
[TBL] [Abstract] [Full Text] [Related]
6. TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.
Su Z; Sun Z; Wang Z; Wang S; Wang Y; Jin E; Li C; Zhao J; Liu Z; Zhou Z; Wang Y; Chen X; Liu X; Lei Z; Zhang HT
Cell Rep; 2022 Oct; 41(3):111513. PubMed ID: 36261009
[TBL] [Abstract] [Full Text] [Related]
7. Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis: A case report.
Kim Y; Park D; Choi SY; Chung C
Thorac Cancer; 2022 Oct; 13(19):2808-2811. PubMed ID: 35982637
[TBL] [Abstract] [Full Text] [Related]
8. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
[TBL] [Abstract] [Full Text] [Related]
9. Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.
Sato Y; Tanino Y; Nikaido T; Togawa R; Kawamata T; Watanabe N; Sato R; Yamada R; Onuma T; Tomita H; Saito M; Rikimaru M; Morimoto J; Suzuki Y; Minemura H; Saito J; Kanazawa K; Yamada S; Hashimoto Y; Shibata Y
BMC Pulm Med; 2022 May; 22(1):191. PubMed ID: 35549684
[TBL] [Abstract] [Full Text] [Related]
10. Myositis autoantibodies in Iranian myositis patients: assessment the frequency and clinical relevancy.
Ebrahimi M; Rostamian A; Rafiei-Latianee R; Najafizadeh SR; Movaseghi S; Faezi ST; Ghazanfari T
Clin Rheumatol; 2022 Feb; 41(2):533-539. PubMed ID: 34514533
[TBL] [Abstract] [Full Text] [Related]
11. Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report.
Xie JJ; Li B; Xu R; Du XZ; He JZ
BMC Pulm Med; 2021 Jun; 21(1):204. PubMed ID: 34193090
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors for cancer-associated myositis: A large-scale multicenter cohort study.
Li Y; Jia X; Sun X; Shi L; Lin F; Gan Y; Zhang X; Gao X; Miao M; Hong D; Li Y; He J
Int J Rheum Dis; 2021 Feb; 24(2):268-273. PubMed ID: 33369084
[TBL] [Abstract] [Full Text] [Related]
13. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies.
Wong VT; So H; Lam TT; Yip RM
Acta Neurol Scand; 2021 Feb; 143(2):131-139. PubMed ID: 32762037
[TBL] [Abstract] [Full Text] [Related]
14. Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis.
Motegi SI; Sekiguchi A; Ikeuchi H; Sakairi T; Ogawa H; Fujii T; Sohda M; Yajima T; Ida S; Takayasu Y; Shimoda Y; Hiromura K; Saeki H; Shirabe K; Chikamatsu K; Yokoo H; Oyama T; Ishikawa O
J Dermatol; 2020 Dec; 47(12):1395-1402. PubMed ID: 32734678
[TBL] [Abstract] [Full Text] [Related]
15. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of lung cancer.
Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
[No Abstract] [Full Text] [Related]
16. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
[TBL] [Abstract] [Full Text] [Related]
17. Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis.
Nakanishi Y; Yamaguchi K; Yoshida Y; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Miyamoto S; Iwamoto H; Hirata S; Fujitaka K; Hamada H; Sugiyama E; Hattori N
Intern Med; 2020 Oct; 59(20):2553-2558. PubMed ID: 32581161
[TBL] [Abstract] [Full Text] [Related]
18. trim33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
[TBL] [Abstract] [Full Text] [Related]
19. Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of lung cancer.
Pan J; Yu L; Wu Q; Lin X; Liu S; Hu S; Rosa C; Eichinger D; Pino I; Zhu H; Qian J; Huang Y
Mol Cell Proteomics; 2020 Mar; 19(3):490-500. PubMed ID: 31924693
[TBL] [Abstract] [Full Text] [Related]
20. [Dermatomyositis: new antibody, new classification].
Bolko L; Gitiaux C; Allenbach Y
Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():18-23. PubMed ID: 31859626
[TBL] [Abstract] [Full Text] [Related]
[Next]
